Tara Bannow , 2025-05-15 14:07:00
SAN FRANCISCO — Lurking beneath the shiny promise of artificial intelligence in health care is a host of potential liability issues. Chief among them: a lack of consent from patients, whether any doctor checks the machine’s work, and, if they do, whether that even helps.
A panel of legal and medical experts at STAT’s Breakthrough Summit West explained the myriad legal questions hanging over the adoption of AI in health care. The discussion wove notes of caution into an otherwise hopeful collection of conversations about the use of such technology in medical care and drug development.
One of the speakers, Christopher Longhurst, chief clinical and innovation officer at UC San Diego Health, just published an article calling on clinicians to disclose to patients any time generative AI is used in their communications. “We just think that’s the right thing to do,” he said.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
